FDA Import Refusal AEK-0917424-3/10002/1 — HETERO HEALTHCARE LIMITED
The FDA refused shipment AEK-0917424-3/10002/1 from HETERO HEALTHCARE LIMITED (India) on Aug 13, 2026. The refused product falls under Drugs and Biologics — RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal Details
- Date
- Aug 13, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60SDY27 RABEPRAZOLE SODIUM (ANTACID) (ANTI-ULCER)
- Charges
- 75